Your browser version may not work well with NCBI's Web applications. More information
here...
-
Induction of endogenous genes by peroxisome proliferator activated receptor alpha ligands in a human kidney cell line and in vivo.
Liu PC,
Huber R,
Stow MD,
Schlingmann KL,
Collier P,
Liao B,
Link J,
Burn TC,
Hollis G,
Young PR,
Mukherjee R.
Department of Biotechnology, Experimental Station, Bristol-Myers Squibb Company, Wilmington, DE 19880, USA.
The peroxisome proliferator activated receptor alpha (PPARalpha) plays a key role in regulating fatty acid metabolism by regulating expression of genes involved in fatty acid oxidation. To identify endogenous transcripts that could be used as surrogate markers for on-target activity of PPARalpha agonists, we employed a global profiling approach using DNA microarrays. The HK-2 cell line derived from proximal tubules of the human kidney, showed induction of several genes, including pyruvate dehydrogenase kinase 4 (PDK-4) and adipocyte differentiation related protein (ADRP) by PPARalpha ligands. HK-2 cells express detectable levels of PPARalpha and its dimerization partner the retinoid X receptor (RXRalpha) proteins. Induction of PDK-4 in these cells correlates with induction of PDK-4 in the liver of fat-fed hamsters. The magnitude of fibrate induction of PDK-4 in the liver also mirrors the decrease in serum triglyceride levels. Thus, induction of PDK-4 by PPARalpha agonists in the HK-2 cell model closely correlates with its induction in vivo and may represent an early marker for PPARalpha agonist action.
PMID: 12798359 [PubMed - indexed for MEDLINE]
-
Related Articles
-
Patient Drug Information
-
Fenofibrate (Antara®, Lofibra®, TriCor®, ...)
Fenofibrate is used with diet changes (restriction of cholesterol and fat intake) to reduce the amount of cholesterol and triglycerides (fatty substances) in your blood. Accumulation of cholesterol and fats along the wal...